|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9743 USD | -2.12% |
|
+5.70% | +10.29% |
| Fiscal Period: September | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 67.89K | 3.89M | 965K | 1.98M | 2.12M | |||||
Total Revenues | 67.89K | 3.89M | 965K | 1.98M | 2.12M | |||||
Cost of Goods Sold, Total | 2.19M | 4.04M | 1.47M | 2.11M | 3.78M | |||||
Gross Profit | -2.12M | -150K | -503K | -129K | -1.66M | |||||
Selling General & Admin Expenses, Total | 529K | 560K | 469K | 809K | 947K | |||||
Stock-Based Compensation (IS) | 1.73M | 110K | 24.98K | 1.96M | 853K | |||||
Other Operating Expenses, Total | 2.26M | 670K | 494K | 2.77M | 1.8M | |||||
Operating Income | -4.38M | -819K | -997K | -2.9M | -3.46M | |||||
Interest Expense, Total | -176K | -273K | -309K | -359K | -389K | |||||
Interest And Investment Income | - | - | - | 16.53K | 4.07K | |||||
Net Interest Expenses | -176K | -273K | -309K | -342K | -385K | |||||
Currency Exchange Gains (Loss) | 5.43K | -4.86K | -18.49K | 11.9K | 15.94K | |||||
Other Non Operating Income (Expenses) | -79K | -72.16K | -82.93K | -100K | -95.31K | |||||
EBT, Excl. Unusual Items | -4.63M | -1.17M | -1.41M | -3.33M | -3.92M | |||||
Other Unusual Items | - | - | - | - | - | |||||
EBT, Incl. Unusual Items | -4.63M | -1.17M | -1.41M | -3.33M | -3.92M | |||||
Earnings From Continuing Operations | -4.63M | -1.17M | -1.41M | -3.33M | -3.92M | |||||
Net Income to Company | -4.63M | -1.17M | -1.41M | -3.33M | -3.92M | |||||
Net Income - (IS) | -4.63M | -1.17M | -1.41M | -3.33M | -3.92M | |||||
Net Income to Common Incl Extra Items | -4.63M | -1.17M | -1.41M | -3.33M | -3.92M | |||||
Net Income to Common Excl. Extra Items | -4.63M | -1.17M | -1.41M | -3.33M | -3.92M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -0.08 | -0.02 | -0.02 | -0.05 | -0.06 | |||||
Basic EPS - Continuing Operations | -0.08 | -0.02 | -0.02 | -0.05 | -0.06 | |||||
Basic Weighted Average Shares Outstanding | 59.92M | 61.32M | 62.16M | 62.47M | 63.38M | |||||
Net EPS - Diluted | -0.08 | -0.02 | -0.02 | -0.05 | -0.06 | |||||
Diluted EPS - Continuing Operations | -0.08 | -0.02 | -0.02 | -0.05 | -0.06 | |||||
Diluted Weighted Average Shares Outstanding | 59.92M | 61.32M | 62.16M | 62.47M | 63.38M | |||||
Normalized Basic EPS | -0.05 | -0.01 | -0.01 | -0.03 | -0.04 | |||||
Normalized Diluted EPS | -0.05 | -0.01 | -0.01 | -0.03 | -0.04 | |||||
Supplemental Items | ||||||||||
EBITA | -4.38M | -819K | -997K | -2.9M | -3.46M | |||||
EBIT | -4.38M | -819K | -997K | -2.9M | -3.46M | |||||
Normalized Net Income | -2.89M | -731K | -880K | -2.08M | -2.45M | |||||
Interest on Long-Term Debt | 176K | 172K | 205K | 197K | 179K | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | - | - | - | - | - | |||||
Marketing Expenses | 60.5K | 41.06K | 19.73K | 7.19K | 8.42K | |||||
Selling and Marketing Expenses | 60.5K | 41.06K | 19.73K | 7.19K | 8.42K | |||||
General and Administrative Expenses | 258K | 297K | 241K | 382K | 395K | |||||
Research And Development Expense From Footnotes | 1.96M | 3.78M | 1.27M | 1.94M | 3.7M | |||||
Stock-Based Comp., Other (Total) | 1.73M | 110K | 24.98K | 1.96M | 853K | |||||
Total Stock-Based Compensation | 1.73M | 110K | 24.98K | 1.96M | 853K |
- Stock Market
- Equities
- ACHFF Stock
- Financials Arch Biopartners Inc.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















